PDCD1 and melanoma: In addition, abnormal inflammation observed in patients with melanoma and prostate cancer treated with anti-PD-1/PD-L1 antibodies caused by the increased Th1/Th17-dependent secretion of inflammatory cytokines, such as IL-6, IL-17, and IFN-γ, has been shown to be associated with neutrophils [115].